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Electron microscopic and immunohistochemical analysis
of neuroendocrine features in lung tumors
Maria Maksymowicz1, W∏odzimierz Olszewski1, Andrzej Pietraszek2,
El˝bieta Kulczycka1, Danuta Szczypiorska-Wrede1
I n t r o d u c t i o n. Pulmonary tumors display several interesting aspects, especially the relationship between the cell biology
of lung carcinoma and the response of these neoplasms to therapeutic intervention. The clinical significance of neuroendocri-
ne differentiation in lung carcinomas remains unclear and is widely discussed.
M a t e r i a l  a n d  m e t h o d s. Immunohistochemical and electron microscopic evaluations were performed to assess the cor-
relation between the immunohistochemical and ultrastructural evidence of neuroendocrine differentiation in pulmonary
tumors with neuroendocrine features at the histological level. Forty eight surgically treated lung tumors were investigated. All
tumors were classified histologically (depending on hematoxylin and eosin staining) as: carcinoid (5 ases), small cell lung car-
cinoma (2 cases), large cell neuroendocrine carcinoma (4 cases), squamous cell carcinoma (18 cases) and adenocarcinoma
(16 cases). These tumors were immunostained with a panel of neuroendocrine markers (chromogranin A, synaptophysin,
NSE) and cytokeratin. All of them were ultrastructurally investigated for the presence of neuroendocrine dense core granules.
Re s u l t s. The presence of neurosecretory granules was directly correlated with immunodetection of neuroendocrine markers:
chromogranin A and synaptophysin. Immunoreactivity for NSE was not significant and this marker does not appear to be use-
ful for detecting neuroendocrine features in pulmonary tumors. The results of this study indicate, however, that carcinomas wi-
thout histologic features of neuroendocrine differentiation may show positive immunoreactivity to investigated markers.
Our findings also demonstrate that 32% of adenocarcinomas were positive for chromogranin A and 62% – for synaptophy-
sin; in squamous cell carcinomas 33% were positive for synaptophysin. We did not find any neuroendocrine features at ultra-
structural level in this tumors.
S u m m a r y. Positive immunoreactivity for selected neuroendocrine markers does not always correlate with light and electron
microscopy characteristics of lung tumors.
Mikroskopowo-elektronowa i immunohistochemiczna
ocena neuroendokrynnoÊci w nowotworach p∏uc
W p r o w a d z e n i e. Celem pracy by∏a ocena mikroskopowo-elektronowa i immunohistochemiczna nowotworów p∏uc ze szcze-
gólnym uwzgl´dnieniem korelacji ultrastruktury guza i reakcji immunohistochemicznych w nowotworach p∏uca, wykazujàcych
histologiczne cechy neuroendokrynnoÊci.
M a t e r i a ∏  i m e t o d y. Zbadano 48 przypadków nowotworów p∏uca leczonych chirurgicznie w Centrum Onkologii w latach
1997-1999, w tym 5 przypadków rakowiaka, 2 – raka drobnokomórkowego, 4 – raka wielkokomórkowego neuroendokrynne-
go oraz 18 przypadków raka p∏askonab∏onkowego i 16 przypadków gruczolakoraka. Wykonano odczyny immunohistoche-
miczne przeciwcia∏ami skierowanymi przeciwko wybranym markerom neuroendokrynnoÊci (chromogranina A, synaptofizy-
na i NSE) oraz cytokeratynie. Wszystkie guzy poddano analizie w mikroskopie elektronowym pod kàtem obecnoÊci charak-
terystycznych ziarnistoÊci neuroendokrynnych w komórkach nowotworowych.
W y n i k i. We wszystkich przypadkach, w których w obrazie ultrastrukturalnym stwierdzono obecnoÊç ziarnistoÊci neuroendo-
krynnych, badanie immunohistochemiczne na obecnoÊç chromograniny A i/lub synaptofizyny wykaza∏o dodatni odczyn. Wy-
kazano niskà swoistoÊç odczynu na NSE. W przypadkach, gdzie obraz histologiczny przemawia∏ za neuroendokrynnym
charakterem guza, stwierdzono ziarnistoÊci neuroendokrynne w obrazie mikroskopowo-elektronowym. Nie stwierdzono na-
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Introduction
Lung carcinoma is one of special interest for epidemiolo-
gists, genetics, pathologists and clinicians as the most
common malignancy observed in developed countries. In
spite of generally unfavorable prognosis there are signifi-
cant differences in biology and responses to treatment
depending on histologic type of tumors. The simplest and
most widely used method of classification recognizes four
major histologic types of lung carcinoma: squamous cell
carcinoma, small cell carcinoma, adenocarcinoma and
large cell undifferentiated carcinoma [1]. Considering
the biology of these tumors, their staging and their re-
sponse to implement treatment lung carcinomas can be
divided into small cell carcinoma and non-small cell car-
cinomas. This classification is justified in view of genetics,
histogenesis, morphology and especially response to tre-
atment. Small cell carcinoma belongs to the group of
neuroendocrine tumors which, in the lung, originate from
Kulchitzky cells. These cells are normally found in the
bronchial and bronchiolar epithelium and mucosa glands
[2]. The Kulchitzky cells, like other neuroendocrine cells,
are capable of decarboxylation of biogenic amins and of
the collection and secretion of endocrine products (NSE,
NCAM, synaptophysin and other). Ultrastructural featu-
res of these cells are characterized by a presence of den-
se-core granules in the cytoplasm. These granules me-
asure from 50–450 nm.
Introduction of electron microscopy and immunohi-
stochemistry increased interest and recognition of neuroen-
docrine neoplasms. For many years only two major catego-
ries of pulmonary neuroendocrine tumors were recognized:
carcinoid and small cell carcinoma. At present four catego-
ries of these tumors are recognized: carcinoid, atypical
carcinoid, large cell carcinoma and small cell carcinoma,
which comprise a spectrum of malignancies. This classifica-
tion of lung tumors was included into the new version of
the WHO classification, which had been published recen-
tly [3, 4]. Three grades of malignancies of pulmonary neu-
roendocrine neoplasms are recognized: low-grade – carci-
noid, intermediate grade – atypical carcinoid and high gra-
de – large cell carcinoma and small cell carcinoma.
To diagnose tumor as belonging to the neuroendocri-
ne family certain microscopic features should be found.
They inlude a specific type of chromatin structure (so
called „salt and pepper”), and cell arrangement (rosette
and /or palisades). The diagnosis of neuroendocrine cha-
racter of a tumor should be confirmed by ultrastructural
evaluation (the presence of neuroendocrine granules)
and/or positive immunoreactivity for chromogranin A and
synaptophysin. Other markers, such as neuroendocrine
[5], hormonal and epithelial [6], molecular [7] or so-called
„lymphoidal” [8] can be also implemented.
Objective
The aim of the study was to peform electron microscopic
and immunohistochemical evaluation of lung tumors in
order to assess the correlation between the ultrastructural
and immunohistochemical evidence of neuroendocrine
differentiation in pulmonary tumors with neuroendocrine
features at the histological level in H&E stain slides.
Material
Forty eight tumors of the lung from patients treated surgically at
the Department of the Lung and Chest Tumors of the Institute
of Oncology in Warsaw, between the years 1997 and 1999 were
investigated. Only cases of primary surgical treatment were selec-
ted, cases pretreated with chemotherapy or radiotherapy were
not included in the study.
Methods
L i g h t  m i c r o s c o p y. For light microscopy analysis all tissue
specimens were formalin fixed and embedded in paraffin. The
sections were routinely stained with hematoxylin and eosin and
then examined for histologic diagnosis. The tumors were classi-
fied according to the WHO system [1, 4] and the specimens for
immunochstochemical investigation were selected.
I m m u n o h i s t o c h e m i s t r y . The identification of chosen
markers was determined by immunohistochemical staining
with the monoclonal, affinity-puriffied antibodies (DAKO,
Denmark): anti-chromogranin A, DAK-A3 clone (kat.no
M0869), anti-NSE, BBS/NC/VI-H14 clone (kat.no. M0873),
anti-cytokeratin, MNF 116 clone (kat.no. M0821) and poliklo-
nal: anti-synaptophysin (kat.no. A0010). After deparaffinization
and rehydratation, the slides underwent pretreatment microwa-
ve boiling in 0,01 M citric acid buffer, pH 6,0 (600 W for 12
min.). Endogenous peroxidase activity was blocked with 3%
H2O2. Incubation with specific antibodies diluted 1:50 in TRIS-
-buffered saline (TBS) pH 7,6 supplemented with 1% bovine
albumin (fraction V, Sigma, kat.no A-9647) was performed for
60 min. at room temperature in a moist chamber. The reactivi-
ty of primary antibodies was detected with streptavidin-biotin
complex peroxidase technique with LSAB-kit (DAKO, LSAB
Universal Plus KIT/HRP, kat.no K0690). The reaction pro-
duct was visualized by 3,3'-diaminobenzidine tetrahydrochlori-
de (DAKO, DAB+ Substrate Chromogen, kat.no K3468) as
chromogen. Finally, the sections were lightly counterstained
with hematoxylin.
For evaluation an immunohistochemical staining 4-steps
scale from (-) to (+++) was used; (-) was categorized as nega-
tomiast ultrastrukturalnych wyk∏adników neuroendokrynnoÊci w rakach p∏askonab∏onkowych i gruczo∏owych, choç cz´Êç z nich
wykazywa∏a dodatni odczyn w reakcjach immunohistochemicznych.
Po d s u m o w a n i e.  W guzach p∏uc dodatni odczyn immunohistochemiczny na markery neuroendokrynne nie zawsze
odpowiada histologicznemu i ultrastrukturalnemu charakterowi tych nowotworów.
Key words: lung carcinoma, neuroendocrine tumors, electron microscopy, immunohistochemistry, chromogranin A, sy-
naptophysin, NSE
S∏owa kluczowe: rak p∏uca, nowotwory neuroendokrynne, mikroskopia elektronowa, immunohistochemia, chromo-
granina A, synaptofizyna, NSE
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tive; (+++) categorized as strongly positive staining of tumor
cells.
E l e c t r o n  m i c r o s c o p y.  For ultrastructural investigations
small samples of tissue taken from resected pulmonary tumors
were immersed in 2.5% glutaraldehyde and 2% paraformaldehy-
de in 0.1 M sodium cacodylate buffer pH 7.4 and postfixed in 1%
osmium tetroxide with 0.8% potassium ferrocyanide (Sigma,
kat.no P-3289), dehydrated in a graded series of ethanol and
embedded in Epon 812. Semithin 1µm sections were stained
with toluidine blue and viewed under Olympus BX60 light mi-
croscope. Ultrathin sections were contrasted with uranyl ace-
tate and Reynold's lead citrate and examined under Philips CM
120 BioTWIN transmission electron microscope.
Results
H i s t o p a t h o l o g y
Basing on H&E stained slides histological diagnosis had
been established: squamous cell carcinoma – 18 cases,
adenocarcinoma – 16 cases, small cell carcinoma – 2 ca-
ses, carcinoid – 5 cases and large cell carcinoma with hi-
stologic neuroendocrine features – 5 cases. Three tumors
have presented mixed structures.
In 2 cases adenocarcinoma and squamous cell carci-
noma structures have been found and 1 case had presen-
ted mixed subtype of small cell carcinoma (small cell and
adenocarcinoma, Fig. 1a). Based on light microscopic fe-
atures 2 of 5 carcinoids were classified as typical carcino-
ids. The tumor cells had presented regular tissue arrange-
ment; no mitotic figures or necrosis were present (Fig.
1b). The remaining 3 tumors were diagnosed as atypical
carcinoids, with tumor cells presenting some polymor-
phism, mitotic figures and small area of necrosis (puncta-
te necrosis). In 4 cases of non-small cell carcinoma micro-
scopic features presented organoid arrangement of tumor
cells with extensive necrosis and palisade arrangement
of tumor cells at the periphery of solid areas of tumor
growth. These tumors were classified as non-small cell
carcinoma with neuroendocrine features. The number of
tumors in each histologic category is shown in Table I.
Male constituted 61 % of the patients. The mean
age of patients was 60 years.
In the majority of patients (65%) their symptoms
were related to respiratory tract and in 2 patients symp-
toms were related to brain metastases (headache and diz-
ziness). In 1 case of carcinoid the patient presented Cu-
shing's syndrome due to ectopic secretion of ACTH. Ele-
ven patients were asymptomatic.
I m m u n o h i s t o c h e m i s t r y
Strong positive or positive staining for cytokeratin has
been found in 44 out of the 48 analyzed cases. Strongly
positive staining for NSE has been seen in 29 of 48 cases,
weakly positive in 12 and negative in 7 cases. It has been
found that 77% of squamous cell carcinomas and 81%
of adenocarcinomas were positive for this neuroendocri-
ne marker (Fig. 1c). It should be stressed that all carci-
noids and small cell carcinomas has been positive for
NSE.
Immunoreactivity for chromogranin A has been
strongly positive in 5 cases, weak in 9. All others were
either negative or doubtful. A strongly positive reaction
for this marker was found in 2 typical carcinoids, 2 atypi-
cal carcinoids and 1 adenocarcinoma. Weak reaction has
been found in 1 atypical carcinoid, 1 small cell carcinoma,
4 adenocarcinomas and 3 non-small cell carcinomas with
neuroendocrine features. One small cell carcinoma and
one non-small cell carcinoma has been negative for chro-
mogranin A.
Immunoreactivity for synapthophysin has been con-
sidered as strongly positive in 16 cases. The strong reac-
tion for this marker has been observed in all carcinoids
but also in 3 squamous cell carcinoma and 6 adenocarci-
nomas (Fig. 1d). Weakly positive reaction for synapto-
physin was found in 1 atypical carcinoid, 1 small cell car-
Tab. I. Pulmonary carcinomas. Immunoreactivity for selected neuroendocrine markers does not always correlate with light
and electron microscopy characteristics of lung tumors
Presence of
Histological type of tumor No. of cases No. of cases positive for (weak/very strong) NE granules
ChrA Syn NSE CK in the cytoplasm
Squamous cell carcinoma 18 0/0 3/3 3/11 4/13 0
Adenocarcinoma 16 4/1 4/6 4/9 3/12 0
Typical carcinoid 2 0/2 0/2 0/2 0/2 2
Atypical carcinoid 3 1/2 1/2 0/3 1/2 3
Small cell carcinoma 2 1/0 1/1 0/2 0/2 2
Large cell neuroendocrine carcinoma 4 3/0 3/1 4/0 1/2 4
Combined small cell carcinoma 2 0/0 0/0 0/2 1/0 0
Clear cell carcinoma 1 0/0 0/1 1/0 1/0 0
Total no. of cases 48 9/5 12/16 12/29 11/33 11
cinoma, and 3 non- small cell carcinomas with histologic
neuroendocrine features.
E l e c t r o n  m i c r o s c o p y
On the ultrastructural level typical neuroendocrine granu-
les have been found in small cell carcinomas, all carci-
noids (typical and atypical) and in all non-small cell carci-
nomas with neuroendocrine features.
Cells of small cell carcinomas contained neuroen-
docrine dense-core granules. These granules were pre-
sent in small number and occasionally aggregated in one
pole of a cell. They were round or oval and ranged betwe-
en 120–250 nm in size. Electron–density of these granules
were relatively variable in our material. It was often diffi-
cult to distinguish them from primary lysosomes. The
cells has scanty cytoplasm poor in intracytoplasmic or-
ganelles, confined to a few mitochondria and small ci-
sterne of cytoplasmic reticulum. Occasionally, a few small
desmosomes with thin bundles of tonofilaments were ob-
served in neighboring cells.
Neuroendocrine granules were numerous in large
cell carcinoma (Fig. 2a). They were round, uniform, but
usually smaller (approximately 120–150 nm in diameter)
and their limiting membranes were separated by a narrow
halo from the dense core. Their morphology was different
from primary lysosomes; they were rather numerous in
this carcinoma. Sometimes tonofilament bundles close
to dense core granules were found (Fig. 2b). Cells of lar-
ge cell carcinoma were polymorphic and large in size.
They possessed cytoplasm rich in organelles, well-develo-
ped Golgi system, numerous mitochondria and lysoso-
mes. Intracytoplasmic lumina lined by small microvilli
and less numerous desmosomal attachments have been
found.
Cells of carcinoids, both typical and atypical
(Fig. 2c) contained dispersed, numerous neurendocrine
granules that vary considerably in shape (from round
to oval) and size (from 100 to 350 nm). The density
of the cores was variable, but most of them had
high electron density. Sometimes, in one cell two kinds
of dense-core granules have been found. In some cells
of typical carcinoid the cytoplasm was filled with mi-
tochondria which were closely packed and possessed
oncocytic features (Fig. 2d). Some desmosomes and
few tonofilament bundles had been found. Occasionally,
nests of tumor cells were enclosed by a basal lamina.
Cytoplasm of carcinoid tumor cells contained well-deve-
loped rough endoplasmic reticulum. Some cells had
shown intermediate filaments and intracytoplasmic lu-
mina with smooth surface. Cells of atypical carcinoids
presented greater nuclear polymorphism. Neuroendocri-
ne granules were fewer in number than in typical carci-
noid cells but a similar spectrum of granule size has be-
en seen.
Fig.1a. Combined small cell carcinoma. A mixture of small cell carci-
noma and adenocarcinoma may be seen (H&E)
Fig. 1b. Typical carcinoid. Please note the organoid arrangement of tu-
mor cells (H&E)
Fig. 1c. Positive reaction for NSE in squamous cell carcinoma Fig. 1d. Positive reaction for synaptophysin in adenocarcinoma
Among 48 cases of lung tumours investigated by
electron microscopy ultrastructural features of neuroen-
docrine differentiation have been found in 11 cases. In
our material neuroendocrine granules in squamous cell
carcinomas and adenocarcinomas were not identified,
even in tumors with immunohistochemical positivity for
one or more markers used to detect neuroendocrine dif-
ferentiation in lung carcinomas.
Fig. 2a. Non-small cell carcinoma with neuroendocrine morphology
(4600x)
Fig. 2b. Neuroendocrine granules and tonofilaments in a cell of non-
-small cell carcinoma with neurendocrine morphology (22000x)
Fig. 2c. Typical carcinoid. Numerous neuroendocrine granules may be
seen in the cytoplasm of tumor cells (6200x)
Fig. 2d. Cell of atypical carcinoid with oncoctic features (9000x)
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Discussion
Our results indicate that positive immunoreactivity for
selected neuroendocrine markers does not always corre-
late with light and electron microscopy characteristics of
lung tumors. We have found that all cases with neuroen-
docrine features on light and electron microscopy levels
were supported by immunoreactivitness for some neuro-
endocrine markers. However, it should be stressed that
a substantial percentage of tumors with positive neuroen-
docrine reactivity have been found to be non-neuroendo-
crine by histological standards. Among adenocarcinomas
32% of the tumours had been positive for chromogranin
A, and 33% of squamous cell carcinoma while 62% of
adenocarcinomas were positive for synaptophysin. Similar
results were reported in literature. Loy and co-workers [5]
have found positive immunoreactivity in 79% of cases,
for at least one marker (including NSE) in carcinomas
which did not show neuroendocrine features on light or
ultrastructural levels. Addis and co-workers [9] have re-
ported up to 35 % positive immunoreactivity in non-small
cell carcinomas, mostly squamous cell carcinoma.
Use of special techniques like electron microscopy,
immunohistochemistry and molecular biology techniques is
useful in the evaluation of lung neuroendocrine tumours,
but still it may not be the basis for their classification [10].
Considering immunohistochemistry the most reliable neu-
roendocrine markers are chromogranin A, synaptophysin,
Leu-7 and PGP 9.5. Therefore the use of a panel of these
markers is recommended [11]. Based on literature data
and our results NSE seems to be a marker of low value in
differential diagnosis. This marker is positive in almost all
neuroendocrine tumours, but also positive in a high percen-
tage of non-neuroendocrine neoplasms [12, 13].
In general, commercially available antibodies used as
neuroendocrine markers are not specific enough to dia-
gnose pulmonary neurendocrine carcinomas [5]. It should
be taken into consideration in differential diagnosis in
cases when it may lead to therapeutical decisions.
The present classification of lung tumors is based
on histological characteristic found in H&E stained ma-
terial [1, 14]. The microscopic features of carcinoid,
small cell carcinoma, and to some extent of atypical car-
cinoid are very characteristic. The tumor cells present ty-
pically a fine and coarse granular chromatin pattern
(salt & pepper), delicate nuclear membrane and scanty
cytoplasm. Presence of cellular atypia, numerous mitotic
figures and prominent necrosis allows for an easy diffe-
rentiation of small cell carcinoma from carcinoid. The
diagnostic problems do exists in low differentiated tu-
mors, in which neuroendocrine differentiation indica-
tes a different biology of a neoplasm with more aggres-
sive outcome.
Most of small cell carcinomas of the lung show neu-
roendocrine differentiation on immunohistochemistry.
However, it has been noted that even 25–30% of these tu-
mors may be negative for neuroendocrine markers even
when using panel of antibodies [15]. On the other hand
some 10–15 % of non-small cell carcinomas without histo-
logical features of neuroendocrine differentiation are po-
sitive for neuroendocrine immunohistochemical markers
[6]. These data indicate a critical approach to the immu-
nohistochemical tests and warrant to apply ultrastructural
evaluation in difficult and doubtful cases. If a low diffe-
rentiated tumor requires three or more antibodies to de-
termine the diagnosis, electron microscopy seems to be
a less expensive modality [16]. Different authors present,
however, the absence of neuroendocrine granules on ul-
trastructural evaluation from 5–35% of small cell carcino-
mas [17]. On the other hand, neurendocrine granules ha-
ve been found in all typical and atypical carcinoids [10].
It is suggested that the presence of neuroendocrine
differentiation may have therapeutical and prognostic
value. These opinions are not shared by all authors [18].
On immunohistochemical evaluation neuroendocrine dif-
ferentiation may be found in more than 30% of non-
-small cell carcinomas of the lung. In those tumors positi-
ve correlation has been found between the presence of
neuroendocrine markers and the response to chemothe-
rapy. It is suggested that this observation should be consi-
dered while undertaking therapeutical decisions [12].
Schleusener and co-workers [19] have noticed that the
presence of one or two neuroendocrine markers correla-
ted with a longer survival time in the patients treated by
chemotherapy even in high clinical stage (IIIA, IIIB, IV).
From the practical point of view for the appropriate
treatment (and staging) of patients with lung tumors the
separation of small cell carcinoma from non-small carci-
noma is of great significance, especially considering the
clinical consequences of neuroendocrine differentiation in
tumours without microscopic neuroendocrine features.
Further studies are needed to determine whether these
markers have any value in predicting tumour behavior
or response to therapy. In their conclusions, Hua and co-
-workers [20] have suggested to search for new markers,
e.g. so called ”lymphoidal” markers.
Conclusions
1.  Immunoreactivity to cytokeratin and NSE is positive in
a vast majority of lung tumours. NSE reactivity is not
specific enough to differentiate between neuroendocri-
ne and non-neuroendocrine lung carcinomas.
2. Immunoreactivity for chromogranin A and synapto-
physin allows to confirm the neuroendocrine character
of the tumor suggested in light microscopy after
H&E stain.
3. Immunoreactivity for chromogranin A and synapto-
physin was positive in all cases in which neuroendocri-
ne granules on electron microscopic evaluation were
found.
4. In those cases in which light microscopy features are
characteristic for neuroendocrine morphology elec-
tron microscopy the study revealed the presence of
neuroendocrine granules.
5. In all evaluated cases electron microscopy investiga-
tion does not reveal neuroendocrine granules in adeno-
carcinomas and squamous cell carcinomas, even in tu-
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mors positive for neuroendocrine markers in immu-
nohistochemistry.
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